Revive Therapeutics Ltd. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (20)

Latest Posts

About This Stock More About This Stock
E Cannabis And Psychedelic Drug Stock Performances Were Mixed Last Week
Article By: Lorimer Wilson
Saturday, September 11, 2021 7:32 AM EST
The performance of the psychedelic-focused index components substantially outshone the weed stocks.
In this article: RVVTF, MYCOF, FTRPF, ENVB, ALID, AWKNF
Read
E Which Psychedelic Drug Stock Category Outperformed This Past Week?
Article By: Lorimer Wilson
Sunday, August 15, 2021 6:00 AM EST
Which has performed best lately, the Pure-Play Marijuana Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index?
In this article: RVVTF, TBPMF, MYCOF, DMTTF
Read
E Marijuana Drug Stocks: All You Need To Know
Article By: Lorimer Wilson
Friday, August 13, 2021 4:53 AM EST
Eight clinical-stage companies are researching the treatment of a wide variety of illnesses using marijuana. Six have market capitalizations between $50M and $500M; two are between $37M-$50M.
In this article: ZYNE, CRBP, RVVTF, TBPMF, MGCLF, ZLDAF, ENVB, ALID
Read
E Cannabis-Centric Bio-Pharma Stocks Category Declined Almost 3% This Past Week
Article By: Lorimer Wilson
Sunday, April 25, 2021 3:00 AM EST
Introducing our new Cannabis-Centric Bio-Pharma Stocks Index of the 13 clinical-stage biopharmaceutical companies involved exclusively in the development of drugs using CBD and THC.
In this article: GWPH, ZYNE, CRBP, VBIO, RVVTF, CNBX, TBPMF, IMLFF, MGCLF, ZLDAF, ARTL, ENVB
Read
E Pure-Play Psychedelic Drug Stocks Index Declined 5.7% This Week
Article By: Lorimer Wilson
Saturday, April 17, 2021 7:33 AM EST
In the past week, of the 41 psychedelic drug stocks that trade on the various North American stock exchanges only nine went up in price, while 31 went down and one had no change.
In this article: LKYSF, CMPS, JAGX, RVVTF, MMEDF, FTRPF, SEEL, CLXPF, BNOEF
Read

Latest Tweets for $RVVTF

No tweets yet!

PARTNER HEADLINES

$RVVTF

Traumatic Brain Injury: Six Psychedelics Companies Target $120 Billion Market
James Hunter 3/25/2021 3:11:59 AM

Thanks for sharing: RVV mentioned in article: "Revive Therapeutics (CAN: RVV / US: $RVVTF) plans to seek IND status from the FDA in Q2 2021, for its psilocybin-based research on TBI. With a different (non-psychedelic) drug already in a Phase III clinical trial, Revive has more experience in formal clinical research. But TBI is not the principal focus of its R&D."

1 to 1 of 1 comments